After Hours
There may be slightly higher risks associated with pre-market and after-hours trading than during regular market hours. Due to the fact that issuers often announce critical financial information outside of regular trading hours, extended-hours trading may result in wider spreads for particular securities.
Stocks Info
As a NASDAQ listed company, IMVT falls under the Healthcare sector while operating within the Biotechnology industry segment. The current market capitalization of Immunovant Inc is $3.19B. A total of 1.15 million shares were traded on the day, compared to an average of 1.46M shares.
In the most recent transaction, Fromkin Andrew J. sold 8,000 shares of IMVT for 19.60 per share on Mar 07 ’25. After the transaction, the Director now owns 91,913 company shares. In a previous transaction on Mar 07 ’25, ANDREW J FROMKIN bought 8,000 shares at 19.52 per share.
Among the insiders who sold shares, Macias William L. disposed of 2,055 shares on Feb 19 ’25 at a per-share price of $20.86. This resulted in the Chief Medical Officer holding 357,353 shares of IMVT after the transaction. In another insider transaction, Barnett Eva Renee sold 2,814 shares at $20.86 per share on Feb 19 ’25. Company shares held by the Chief Financial Officer now total 321,952.
In spite of price targets being rarely accurate, it tends to exert some kind influence from time to time, and was often accepted by the market as having some value. In terms of 52-week highs and lows, IMVT has a high of $34.47 and a low of $17.01.
Balance Sheet Annually/Quarterly
The balance sheet of a company shows what assets and liabilities a company has, as well as the amount, equity investors have invested. With the help of this information, a company’s financial ratios can be calculated to give investors an overview of the company’s prospects. IMVT’s latest balance sheet shows that the firm has $493.82M in Cash & Short Term Investments as of fiscal 2022. There were $2.36M in debt and $44.52M in liabilities at the time. Its Book Value Per Share was $2.40, while its Total Shareholder’s Equity was $469.82M.
Analysts Opinion
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for IMVT is Buy with a score of 4.73.
